about
Insulin-like growth factor binding proteins: a structural perspective.Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infantsIPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.New therapeutic targets for amyotrophic lateral sclerosis.Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes.Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development.Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALSIPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet
P2860
Q30417447-EADE3DF7-8597-43CA-849A-4F5A76C85609Q35010965-6E197EBA-4885-45B7-A60F-501CCCCC2A8BQ35800245-940EFE75-45A0-4DE8-AA9E-F5465BABBF8CQ36327383-11961871-5A7B-4BAF-BD3D-95161962DFC3Q37816447-DA7E0CE2-63E8-46A3-B35E-A9505FBF926AQ38128225-ECDCBE17-6898-4066-9FB8-397D57562226Q38589015-E2A1B425-D948-4F18-8C77-3C41963AC9F2Q38729143-907AEDB6-24E2-4C80-B0B0-D8DB25287499Q44478641-4BA91910-D965-436C-BE37-9B2E8FC269DCQ45899514-7974F4F9-D6F5-45EA-B86B-B76B2FF12A3BQ47568034-C7010759-C96C-48E2-8FF6-D01C8DA29696Q52563288-3E19ECEE-B5B1-4028-8CF0-B826309822BAQ58125227-BDDCDB45-277F-494C-9B10-1DACF7373003Q58307250-07126ECF-CA3C-4D9A-BEDE-8DD00682B7FF
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@ast
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@en
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@nl
type
label
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@ast
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@en
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@nl
prefLabel
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@ast
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@en
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@nl
P2093
P2860
P356
P1476
Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX
@en
P2093
Anna McDonald
Martin O'Savage
Rachel M Williams
P2860
P304
P356
10.1517/17425255.4.3.311
P407
P577
2008-03-01T00:00:00Z